Acro Biomedical (ACBM) Cash from Operations (QoQ) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - |
| 10 | Acro Biomedical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 53.36% |
| Sep 30, 2025 | 42.11% |
| Jun 30, 2025 | -317.13% |
| Mar 31, 2025 | -114.27% |
| Dec 31, 2024 | -65.98% |
| Sep 30, 2024 | -0.09% |
| Jun 30, 2024 | 53.16% |
| Mar 31, 2024 | -7.14% |
| Dec 31, 2023 | -2,711.39% |
| Sep 30, 2023 | -78.53% |
| Jun 30, 2023 | 140.42% |
| Mar 31, 2023 | 47.33% |
| Dec 31, 2022 | 80.16% |
| Sep 30, 2022 | 84.59% |
| Jun 30, 2022 | -231.91% |
| Mar 31, 2022 | 533.23% |
| Dec 31, 2021 | 6.26% |
| Sep 30, 2021 | -114.92% |
| Jun 30, 2021 | 5,264.32% |
| Sep 30, 2020 | 10.07% |
| Jun 30, 2020 | -176.12% |
| Mar 31, 2020 | -174.48% |
| Dec 31, 2019 | 136.91% |
| Sep 30, 2019 | 31.18% |
| Jun 30, 2019 | -162.75% |
| Mar 31, 2019 | -130.02% |
| Dec 31, 2018 | 4,283.56% |
| Sep 30, 2018 | 99.19% |
| Jun 30, 2018 | -225.16% |
| Mar 31, 2018 | 1,330.81% |
| Dec 31, 2017 | 92.01% |
| Sep 30, 2017 | -2,270.83% |
| Jun 30, 2017 | 40.44% |
| Mar 31, 2017 | -20,655.63% |
| Dec 31, 2016 | 98.52% |
| Sep 30, 2016 | -71.54% |
| Jun 30, 2016 | 31.40% |
| Mar 31, 2016 | 28.18% |
| Dec 31, 2015 | -648.88% |